Hyderabad: Hyderabad-based Optimus Pharma launched their frontline Covid-19 medication molnupiravir in the Indian market, as they have received permission for the restricted emergency use for Covid-19 ...
When given early, the antiviral drug molnupiravir (Lagevrio) halved the risk of COVID-19 death and reduced all-cause deaths among older adults in the Czech Republic in 2022, findings published ...
A randomized, controlled UK trial published today in the Lancet shows that the antiviral drug molnupiravir doesn't prevent COVID-19 hospitalizations or deaths in high-risk, nonhospitalized, vaccinated ...
Hyderabad: Hyderabad-based Optimus Pharma launched their frontline Covid-19 medication molnupiravir in the Indian market, as they have received permission for the restricted emergency use for Covid-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback